Remy Luthringer
CIK: 0001610384
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Minerva Neurosciences, Inc.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jun 3, 2026NERV
Minerva Neurosciences, Inc.
Award(A)DirectEmployee Stock Option (right to buy)
1.7M shares- - Dec 22, 2025NERV
Minerva Neurosciences, Inc.
Award(A)DirectEmployee Stock Option (right to buy)
2.3M shares- - Dec 5, 2024NERV
Minerva Neurosciences, Inc.
Award(A)DirectEmployee Stock Option (right to buy)
105K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 3, 2026 | NERV Minerva Neurosciences, Inc. | Award(A) Employee Stock Option (right to buy) | 1,690,700 | - | - | Direct |
| Dec 22, 2025 | NERV Minerva Neurosciences, Inc. | Award(A) Employee Stock Option (right to buy) | 2,250,000 | - | - | Direct |
| Dec 5, 2024 | NERV Minerva Neurosciences, Inc. | Award(A) Employee Stock Option (right to buy) | 105,000 | - | - | Direct |
1-3 of 3 transactions
About Luthringer Remy
Luthringer Remy (SEC CIK 0001610384) files insider reports with the SEC as CEO of Minerva Neurosciences, Inc. (NERV).
Signal8 holds 3 ownership filings by Luthringer Remy, all Form 4s, filed between Dec 6, 2024 and Jun 5, 2026. Those filings report 3 transactions, from Dec 5, 2024 to Jun 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Luthringer Remy's filings is in BURLINGTON, MA.
Recent filings by Luthringer Remy
Other insiders filing for Minerva Neurosciences, Inc. (NERV)
- Kaul Inderjit, Director
- Reilly Joseph H., Chief Operating Officer
- Aliquo Anthony, Chief Accounting Officer
- Ahlholm Frederick W, SVP, CFO and Secretary
- Laghrissi-Thode Fouzia, Director
- Kupfer David, Director